Trust Point Inc. Has $1.85 Million Stake in Colgate-Palmolive (NYSE:CL)

Trust Point Inc. boosted its stake in Colgate-Palmolive (NYSE:CL) by 2.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,327 shares of the company’s stock after buying an additional 417 shares during the quarter. Trust Point Inc.’s holdings in Colgate-Palmolive were worth $1,848,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Algert Global LLC raised its position in Colgate-Palmolive by 14.4% in the 2nd quarter. Algert Global LLC now owns 5,131 shares of the company’s stock valued at $498,000 after purchasing an additional 647 shares during the last quarter. Czech National Bank raised its position in Colgate-Palmolive by 6.5% in the 3rd quarter. Czech National Bank now owns 166,449 shares of the company’s stock valued at $17,279,000 after purchasing an additional 10,106 shares during the last quarter. Park Avenue Securities LLC raised its position in Colgate-Palmolive by 38.3% in the 3rd quarter. Park Avenue Securities LLC now owns 10,705 shares of the company’s stock valued at $1,111,000 after purchasing an additional 2,966 shares during the last quarter. GAMMA Investing LLC raised its position in Colgate-Palmolive by 32.4% in the 3rd quarter. GAMMA Investing LLC now owns 10,952 shares of the company’s stock valued at $1,137,000 after purchasing an additional 2,677 shares during the last quarter. Finally, Miracle Mile Advisors LLC raised its position in Colgate-Palmolive by 19.8% in the 3rd quarter. Miracle Mile Advisors LLC now owns 3,842 shares of the company’s stock valued at $399,000 after purchasing an additional 636 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.05 on Tuesday. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The firm has a market capitalization of $71.12 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 3.61 and a beta of 0.44. The business has a 50-day simple moving average of $91.35 and a 200 day simple moving average of $97.15. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 earnings per share. On average, research analysts anticipate that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CL shares. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday. Finally, Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.